anastrozole has been researched along with Bone Cancer in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective phase III trial comparing anastrozole with tamoxifen as first-line therapy in postmenopausal, hormone-dependent, advanced breast cancer (ABC)." | 9.10 | Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study. ( Casanovas, J; Milla, L; Milla-Santos, A; Pons, M; Portella, J; Puig-Gali, M; Rallo, L; Rodes, E, 2003) |
| "We report three cases with advanced breast cancer were treated with a weekly dose of paclitaxel (TXL)." | 7.73 | [Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel]. ( Katsumine, Y; Noda, N; Osawa, I; Uehara, S; Yuasa, H, 2005) |
| "Osteoprotegerin (OPG) is a potent antiresorptive molecule that binds NF-kappaB ligand, the final effector for osteoclastogenesis." | 5.32 | Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. ( Bajetta, E; Bombardieri, E; Del Vecchio, M; Ferrari, L; La Torre, I; Longarini, R; Martinetti, A; Paleari, D; Seregni, E; Toffolatti, L; Zilembo, N, 2004) |
| "A prospective phase III trial comparing anastrozole with tamoxifen as first-line therapy in postmenopausal, hormone-dependent, advanced breast cancer (ABC)." | 5.10 | Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study. ( Casanovas, J; Milla, L; Milla-Santos, A; Pons, M; Portella, J; Puig-Gali, M; Rallo, L; Rodes, E, 2003) |
| " Here, we report an advanced case of breast cancer with vertebra-Th7 metastasis that showed complete response to combined treatments with formalin-fixed autologous tumor vaccine (AFTV), palliative radiation therapy with 36 Gy, and adjuvant chemotherapy with standardized CEF (cyclophosphamide, epirubicin, and 5FU), zoledronic acid, and aromatase inhibitors following mastectomy for the breast tumor." | 3.79 | Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report. ( Kuranishi, F; Ohno, T, 2013) |
| "We report three cases with advanced breast cancer were treated with a weekly dose of paclitaxel (TXL)." | 3.73 | [Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel]. ( Katsumine, Y; Noda, N; Osawa, I; Uehara, S; Yuasa, H, 2005) |
| "Anastrozole was superior to tamoxifen with respect to TTP (median values of 10." | 1.36 | [A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy]. ( Kawachi, H; Kubota, K; Kuwayama, T; Nakagawa, T; Oda, G; Sato, T; Sugihara, K; Yamamoto, K, 2010) |
| "Osteoprotegerin (OPG) is a potent antiresorptive molecule that binds NF-kappaB ligand, the final effector for osteoclastogenesis." | 1.32 | Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. ( Bajetta, E; Bombardieri, E; Del Vecchio, M; Ferrari, L; La Torre, I; Longarini, R; Martinetti, A; Paleari, D; Seregni, E; Toffolatti, L; Zilembo, N, 2004) |
| "Anastrozole has excellent antitumor activity in postmenopausal women, but no data exist on its efficacy in men." | 1.31 | Efficacy of anastrozole in male breast cancer. ( Buzdar, AU; Giordano, SH; Hortobagyi, GN; Valero, V, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuranishi, F | 1 |
| Ohno, T | 1 |
| Mathew, J | 1 |
| Prinsloo, P | 1 |
| Agrawal, A | 1 |
| Gutteridge, E | 1 |
| Marenah, C | 1 |
| Robertson, JF | 1 |
| Cheung, KL | 1 |
| Kusama, H | 1 |
| Okishiro, M | 1 |
| Ishida, T | 1 |
| Sato, Y | 1 |
| Morimoto, Y | 1 |
| Matsushita, K | 1 |
| Hashimoto, T | 1 |
| Kimura, K | 1 |
| Katsura, Y | 1 |
| Nitta, K | 1 |
| Kagawa, Y | 1 |
| Takeno, A | 1 |
| Sakisaka, H | 1 |
| Nakahira, S | 1 |
| Taniguchi, K | 1 |
| Egawa, C | 1 |
| Takeda, Y | 1 |
| Kato, T | 1 |
| Tamura, S | 1 |
| Takatsuka, Y | 1 |
| Oku, K | 1 |
| Goto, T | 1 |
| Nagano, T | 1 |
| Nakatsuka, S | 1 |
| Sansone, P | 1 |
| Ceccarelli, C | 1 |
| Berishaj, M | 1 |
| Chang, Q | 1 |
| Rajasekhar, VK | 1 |
| Perna, F | 1 |
| Bowman, RL | 1 |
| Vidone, M | 1 |
| Daly, L | 1 |
| Nnoli, J | 1 |
| Santini, D | 1 |
| Taffurelli, M | 1 |
| Shih, NN | 1 |
| Feldman, M | 1 |
| Mao, JJ | 1 |
| Colameco, C | 1 |
| Chen, J | 1 |
| DeMichele, A | 1 |
| Fabbri, N | 1 |
| Healey, JH | 1 |
| Cricca, M | 1 |
| Gasparre, G | 1 |
| Lyden, D | 1 |
| Bonafé, M | 1 |
| Bromberg, J | 1 |
| Sakurai, T | 2 |
| Umemura, T | 1 |
| Jinta, E | 1 |
| Suzuma, T | 1 |
| Yoshimura, G | 1 |
| Shimizu, S | 1 |
| Oda, G | 1 |
| Nakagawa, T | 1 |
| Sato, T | 1 |
| Kuwayama, T | 1 |
| Yamamoto, K | 1 |
| Kawachi, H | 1 |
| Kubota, K | 1 |
| Sugihara, K | 1 |
| Mori, K | 1 |
| Chiba, N | 1 |
| Yamamoto, Y | 1 |
| Yonekawa, H | 1 |
| Coleman, RE | 1 |
| Milla-Santos, A | 1 |
| Milla, L | 1 |
| Portella, J | 1 |
| Rallo, L | 1 |
| Pons, M | 1 |
| Rodes, E | 1 |
| Casanovas, J | 1 |
| Puig-Gali, M | 1 |
| Montemurro, F | 1 |
| Russo, F | 1 |
| Martincich, L | 1 |
| Cirillo, S | 1 |
| Gatti, M | 1 |
| Aglietta, M | 1 |
| Regge, D | 1 |
| Martinetti, A | 1 |
| Bajetta, E | 1 |
| Ferrari, L | 1 |
| Zilembo, N | 1 |
| Seregni, E | 1 |
| Del Vecchio, M | 1 |
| Longarini, R | 1 |
| La Torre, I | 1 |
| Toffolatti, L | 1 |
| Paleari, D | 1 |
| Bombardieri, E | 1 |
| Yuasa, H | 1 |
| Katsumine, Y | 1 |
| Uehara, S | 1 |
| Noda, N | 1 |
| Osawa, I | 1 |
| Rai, Y | 1 |
| Ando, M | 1 |
| Sagara, Y | 2 |
| Takahama, T | 1 |
| Matsuyama, Y | 1 |
| Ooi, Y | 1 |
| Giordano, SH | 2 |
| Hortobagyi, GN | 2 |
| Margolis, R | 1 |
| Budd, GT | 1 |
| Singh, AD | 1 |
| Valero, V | 1 |
| Buzdar, AU | 1 |
1 review available for anastrozole and Bone Cancer
| Article | Year |
|---|---|
Current and future status of adjuvant therapy for breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Che | 2003 |
2 trials available for anastrozole and Bone Cancer
| Article | Year |
|---|---|
Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer.
Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neo | 2014 |
Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neo | 2003 |
13 other studies available for anastrozole and Bone Cancer
| Article | Year |
|---|---|
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.
Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bone Neop | 2013 |
[A case of hyoid bone metastasis from breast cancer].
Topics: Aged; Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols | 2014 |
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
Topics: AC133 Antigen; Anastrozole; Androstadienes; Animals; Antigens, CD; Antineoplastic Agents, Hormonal; | 2016 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2009 |
[A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, B | 2010 |
[A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carci | 2002 |
Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
Topics: Adult; Aged; Anastrozole; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Goserelin; Human | 2004 |
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bon | 2004 |
[Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel].
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone N | 2005 |
[Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Carcinoma, Duc | 2005 |
Leuprolide acetate plus aromatase inhibition for male breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy P | 2006 |
Unusual macular degeneration following breast cancer.
Topics: Adenocarcinoma; Anastrozole; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Choroid Neoplas | 2007 |
Efficacy of anastrozole in male breast cancer.
Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Ne | 2002 |